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Abstract
Objective. The aim was to investigate the time course of lower limb disease activity and walking dis-
ability in children with JIA over a 5-year course.
Methods. The Childhood Arthritis Prospective Study is a longitudinal study of children with a new JIA
diagnosis. Childhood Arthritis Prospective Study data include demographics and core outcome varia-
bles at baseline, 6 months and yearly thereafter. Prevalence and transition rates from baseline to
5 years were obtained for active and limited joint counts at the hip, knee, ankle and foot joints; and
walking disability, measured using the Childhood Health Assessment Questionnaire walking subscale.
Missing data were accounted for using multiple imputation.
Results. A total of 1041 children (64% female), with a median age of 7.7 years at first visit, were
included. Baseline knee and ankle synovitis prevalence was 71 and 34%, respectively, decreasing to
8–20 and 6–12%, respectively, after 1 year. Baseline hip and foot synovitis prevalence was <11%, de-
creasing to <5% after 6 months. At least mild walking disability was present in 52% at baseline, stabi-
lizing at 25–30% after 1 year.
Conclusion. Lower limb synovitis and walking disability are relatively common around the time of ini-
tial presentation in children and young people with JIA. Mild to moderate walking disability persisted in
25% of patients for the duration of the study, despite a significant reduction in the frequency of
lower limb synovitis. This suggests that there is an unmet need for non-medical strategies designed to
prevent and/or resolve persistent walking disability in JIA.
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Introduction
JIA is the most common form of inflammatory arthritis in
childhood, with an estimated prevalence of 1 per 1000
children [1]. In JIA, synovitis is the primary disease pa-
thology, and its clinical signs and symptoms include
joint pain, swelling, stiffness and deformities [2–4].
JIA has a predilection for involvement of the lower
limb joints, particularly the knee and ankle [5–7]. Lower
limb synovitis has been associated with abnormal func-
tion in several small-sample cross-sectional studies of
gait and clinical surveys [2, 8–10]. Results from these
studies suggest that some children with JIA have de-
graded gait patterns characterized by decreased walk-
ing speed and step length and altered loading
characteristics [2, 8, 10]. Such impairments typically
manifest as difficulties with undertaking routine func-
tional tasks, including walking and stair climbing.
Walking is the most common form of incidental, free-
living physical activity in children and adolescents [11];
therefore, further research on the long-term impact of
lower limb disease on walking ability in JIA is warranted.
Only one study evaluated the long-term prevalence
and course of lower limb disease activity in children with
JIA [5]. It was found that almost all children with JIA will
experience lower limb joint synovitis at some point over
the course of their disease [5]. Early in the post-
diagnosis stage, 75 and 60% of those with JIA will
experience knee or ankle joint synovitis, respectively,
decreasing to 50% at 1 year post-diagnosis with the in-
troduction of first-line disease-modifying therapies, and
30–40% thereafter [5]. Impairments in physical function,
such as walking disability, associated with lower limb
synovitis [2, 9, 12, 13] were not evaluated.
Composite measures of disease activity are consid-
ered potentially to be reversible with appropriate phar-
macological therapies [14, 15]. In contrast, outcome
measures for the physical function domain incorporate
both reversible and irreversible components [3, 16].
Functional disability scores appear to be highly corre-
lated with active joint counts in early disease, whereas
limited joints counts are highly correlated with disability
and radiographic joint damage with longer disease dura-
tions [3, 16]. These findings suggest that some children
with JIA might be vulnerable to a persistent or progres-
sive course of disability, despite suppression of disease
activity.
Relative to the prevalence and course of general dis-
ability in JIA, which has been well described [3, 16],
walking disability has not been studied. Greater
understanding of the patterns of lower limb joint impair-
ments and how they relate to walking disability over
time might facilitate more effective rehabilitative man-
agement strategies. The objectives of the present study
were to investigate the prevalence and time course of
lower limb disease activity and walking disability in
patients with JIA over the first 5 years after diagnosis
and to identify walking disability trajectories over this 5-
year course.
Methods
Study population
Participants in this study are from the Childhood
Arthritis Prospective Study (CAPS), with details of the
study described elsewhere [17]. In short, CAPS is a mul-
ticentre study in the UK that commenced in 2001, to
identify predictors of short-term and long-term out-
comes of inflammatory arthritis. CAPS participants were
children (aged 16 years at onset) with inflammatory ar-
thritis of at least one joint persisting for 2 weeks, who
were recruited after first presentation to paediatric rheu-
matology. Exclusion criteria are septic arthritis, hae-
marthrosis, arthritis caused by malignancy, trauma or
connective tissue disorders. CAPS complied with the
Declaration of Helsinki and was approved by the North-
West Multi-Centre Research Ethics Committee. Written
informed consent was obtained from the parent(s)/
guardian for participating children, and children consid-
ered able provided age-appropriate assent.
Data collection
At baseline, the rheumatologist clinically examined the
joints, recording the number of limited and active joints
(out of 71 joints), completed a 10 cm physician’s global
assessment (PGA) visual analog scale (range 0–10 cm,
where 10 is the worst score) and assigned an ILAR sub-
type of JIA based on the disease characteristics at pre-
sentation [18]. A joint was considered active if there was
swelling attributable to active synovitis or, in the ab-
sence of swelling, limited motion accompanied by heat,
pain or tenderness [19]. A limited joint was a joint limited
in motion. The parents and child were interviewed by a
rheumatology research nurse, and medical records were
reviewed to extract data on demographics. The parent
or child, where appropriate, completed the childhood
health assessment questionnaire (CHAQ), a measure of
functional disability (range 0–3, where 3 is the worst)
Key messages
. Prognosis for lower limb disease is good, but walking disability persists for many with JIA.
. There may be unmet need for care to prevent and/or resolve walking disability in JIA.
. Evidence is provided for walking disability trajectories including absence, persistent moderate and fluctuating
courses.
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[20], a 100-mm visual analog scale pain scale, and a 10-
cm parent/patient global health measure [parent general
evaluation (PGE)]. The CHAQ was completed by the par-
ent if the child was 10 years old or optionally by the
parent or child if aged 11 years. The active joint count,
PGA and PGE were used to calculate the clinical juve-
nile arthritis disease activity score based on a 27-joint
count (which excludes ESR) [14].
CAPS follow-up data collection
Follow-up study data were captured at 6 months after
first presentation and then annually for 5 years. Data
were extracted from the medical record and included
the most recent rheumatological examination, PGA,
PGE, CHAQ and pain visual analog scale.
Statistical analysis
Patient data between 2001 and December 2015 were
available for analysis. This analysis was limited to chil-
dren who presented to paediatric rheumatology before
September 2010, who were diagnosed with JIA [18],
and who had both active and limited joint counts
recorded and/or had completed the CHAQ on at least
one occasion over a 5-year follow-up period.
Demographic and disease characteristics (active and
limited joint count, PGA, PGE, CHAQ score, excluding
ESR), pain, clinical juvenile arthritis disease activity score
based on a 27-joint count and ILAR subtype as recorded
at 1 year were summarized using descriptive statistics.
Local joint impairments were determined using active
and limited joint counts recorded at the hip, knee, ankle,
subtalar, inter-tarsal, MTP and IP joints and dichotomized
as present (at least one limb affected) or absent (0).
Walking disability was measured using the CHAQ walking
subscale [Is your child able to: (1) walk outside on flat
ground, and (2) climb up five steps? Possible responses
include: without any difficulty, with some difficulty, with
much difficulty, or unable to do.]. CHAQ walking disability
is reported in terms of severity (0¼no disability, 1¼mild
disability, 2¼moderate disability, 3¼ severe disability), as
well as present (1, at least mild disability) or absent (0,
no disability). The prevalence of lower limb synovitis and
walking disability and the severity of walking disability
were calculated as absolute frequencies (n) and percen-
tages (%) of participants. Change between consecutive
follow-ups was calculated as percentages of participants
with new, stable or resolved synovitis (knee and ankle
joints only) and walking disability. Analyses were under-
taken using SPSS 22 (IBM SPSS Statistics for Windows,
version 22.0; IBM, Armonk, NY, USA) and STATA 13
(Stata Statistical Software, release 13; StataCorp LP,
College Station, TX, USA).
Analyses of prevalence for active lower limb joints as-
sumed that some data were missing-not-at-random.
Children with missing data were split into seven groups:
those discharged well, transferred to other clinics (ex-
cluding those who have probably moved to adult serv-
ices), transferred to adult services, moved home
address, lost to follow-up in CAPS, follow-up completed
but with incomplete data, and follow-up missed but with
subsequent return to follow-up. Assumptions were
made regarding these groups based upon the approach
by Shoop-Worrall et al. [21]: participants had no active
lower limb joints at follow-up if they belonged to groups
one, three, five and seven. All other data were assumed
to be missing-at-random and were imputed via multiple
imputation over 20 iterations using STATA 13. Missing
data for prevalence of limited joints and walking disabil-
ity were all assumed to be missing-at-random and thus
were imputed via multiple imputation over 20 iterations
(see Supplementary Data, section Methods for handling
missing data, available at Rheumatology Advances in
Practice online). Multiple imputations were not under-
taken where the observed prevalence for individual af-
fected joints was low (<5% at follow-up). Secondary
analyses included graphical explorations of complete
(referred to as closed cohort), incomplete (open
cohort) and imputed case analyses for active/limited
joints and presence/absence of walking disability (see
Supplementary Figs S1–8, available at Rheumatology
Advances in Practice online).
Transition rates for walking disability states for the en-
tire sample between follow-ups were explored using the
TraMineR categorical sequence data package for R [22]
and are expressed as absolute frequencies and percen-
tages. A transition is defined as the sequence of walking
disability states between any two successive follow-ups
(for example, an improvement from severe to moderate
walking disability). Longitudinal trajectories for walking
disability states from closed and open cohort data were
explored graphically by constructing a riverplot using
the riverplot R package.
Results
Study population
A total of 1041 children, of whom 64% were female,
with a median age at baseline of 7.7 years (interquartile
range 3.5–11.5 years) were included in the study
(Table 1). A flowchart of study participant recruitment is
provided in Supplementary Fig. S9, available at
Rheumatology Advances in Practice online.
Lower limb joint impairments
Active and limited joint counts were available for 999 chil-
dren at baseline, reducing to 841 (84%) at 6 months, 916
(92%) at 1 year, 852 (85%) at 2 years, 747 (75%) at
3 years, 666 (67%) at 4 years, and 576 (58%) at 5-year
follow-up. A total of 204 children had complete baseline
and all subsequent follow-ups over 5 years (closed co-
hort). The children in the closed cohort differed signifi-
cantly from the open cohort in terms of age [closed:
median 5.8 (interquartile range 2.8–8.7) years; open:
8.8 (3.8–12.1) years; P<0.01], symptom duration [closed:
3 (1–6) months; open: 4 (2–9) months; P¼ 0.02] and
PGA [closed: 3.5 (1.8–6.1) cm; open: 2.8 (1.5–5) cm;
Juvenile arthritis walking disability
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P¼ 0.01]. For the open cohort, baseline knee joint sy-
novitis prevalence was 71%, decreasing to 26% at
6 months and between 8 and 20% after 1 year (Fig. 1A).
Baseline ankle joint synovitis was 34%, decreasing to
18% at 6 months and between 6 and 12% after 1 year.
Baseline hip and foot joints synovitis prevalence was
<11%, decreasing to 2–4% at 6 months and 1–3% af-
ter 1 year. Baseline limited joint prevalence at the knee
was 53%, decreasing to 22% at 6 months and between
9 and 19% after 1 year (Fig. 1B). Baseline limited joint
prevalence at the ankle was 21%, decreasing to 12%
at 6 months and 6–8% after 1 year. Baseline limited
joint prevalence at the hip and foot joints was <10%,
reducing to between 2 and 6% at 6 months and 0–
5% after 1 year. Open cohort prevalence estimates
were consistent with closed cohort estimates (see
Supplementary Figs S1–8, available at Rheumatology
Advances in Practice online). Imputed prevalence esti-
mates were highly consistent (to within 2.5%) with the
original data (open cohort) at each time point.
Change in active joint synovitis state between
follow-ups
The hip joint remained largely quiescent between each
subsequent follow-up, with >91% of participants having
stable inactive hip joints, 0.5–1% having stable active dis-
ease, and 0.5–2% developing new active disease
(Fig. 2A). At the knee, 23% had stable active synovitis
from 0 to 6 months, decreasing to 9% from 6 months to
1 year and 5–6% thereafter (Fig. 2B). New instances of
knee synovitis were observed for between 7 and 12% of
participants at subsequent follow-ups. After 1 year, be-
tween 70 and 75% of participants had stable inactive
knee joints. At the ankle, 13% had stable active synovitis
from 0 to 6 months, decreasing to 5% from 6 months to
1 year and 3–5% thereafter (Fig. 2C). New instances of
ankle synovitis were observed for 5–11% of participants
at subsequent follow-ups. After 1 year, 80% of partici-
pants had stable inactive ankle joints. The subtalar joint
remained largely quiescent, with >86% of participants
having stable inactive subtalar joints, 0–1.5% having sta-
ble active disease, and 2–3% developing new active dis-
ease (Fig. 2D). Imputed estimates consistently exceeded
original data for inactive stable disease by up to 10%.
Walking disability
CHAQ walking disability scores were available for 737
children at baseline, reducing to 669 (91%) at 6 months,
727 (99%) at 1 year, 663 (90%) at 2 years, 592 (80%) at
3 years, 519 (70%) at 4 years, and 454 (62%) at 5-year
follow-up. A total of 173 (23%) children completed base-
line and all subsequent follow-ups over 5 years (closed co-
hort). These patients differed significantly from those with
missing data for age [closed: 6.3 (2.8–10.1) years; open:
8.1 (3.8–11.9) years; P<0.01] and overall CHAQ score
[closed: 0.5 (0.125–1.125); open: 0.75 (0.125–1.5);
P¼ 0.01]. For the open cohort, at least mild walking dis-
ability was present in 52% at baseline, reducing to 37%
at 6 months, 33% at 1 year, and stabilizing at 25–31%
thereafter. Moderate walking disability was more fre-
quently observed at each time point relative to mild and
severe walking disability (Fig. 3A), with 33% of participants
having moderate walking disability at baseline, reducing to
25% at 6 months, 23% at 1 year and 17–23% thereafter.
Mild walking disability was observed in 15% at baseline,
reducing to 10% at 6 months, 9% at 1 year and 6–9%
thereafter. Severe walking disability was relatively infre-
quent and was observed in 5% of participants at baseline,
2% at 6 months and <1% thereafter. Open cohort
prevalence estimates were consistent with closed cohort
estimates (see Supplementary Figs S1–8, available at
Rheumatology Advances in Practice online). Imputed prev-
alence estimates were highly consistent (to within 1%)
with the original data (open cohort) at each time point.
Change in walking disability states between
follow-ups
Proportional increases were observed for participants
with a stable absence of walking disability, from 41% at
baseline to 6 months, to 54–67% thereafter. Stable walk-
ing disability was frequently observed, affecting 30% of
participants between baseline and 6 months, decreasing
to 23% between 6 months and 1 year, and between 16
and 21% thereafter. New instances of walking disability
were less frequently observed, affecting between 7 and
10% of participants. Proportional decreases were
TABLE 1 Demographic and clinical characteristics at first
presentation
Clinical features n Value
Age, median (IQR), years 987 7.7 (3.5–11.5)
Female, n (%) 999 642 (64.3)
Active joint count, median (IQR) 999 2 (1–5)
Limited joint count, median
(IQR)
999 1 (1–3)
Physician global assessment,
mean (S.D.), cm
803 3.4 (2.3)
Parent general evaluation,
mean (S.D.), cm
670 2.8 (2.6)
VAS pain, mean (S.D.), mm 717 34.8 (28.3)
CHAQ score, median (IQR) 731 0.625 (0.125–1.375)
cJADAS-27, mean (S.D.) 555 10.3 (7.7)
ILAR subtype, n (%) 1033
Systemic 53 (5.1)
Persistent oligoarthritis 457 (44.2)
Extended oligoarthritis 22 (2.1)
RF-negative polyarthritis 152 (14.7)
RF-positive polyarthritis 30 (2.9)
Enthesitis-related arthritis 54 (5.2)
PsA 70 (6.8)
Unclassifiable 195 (18.9)
Data are reported as n (%) unless otherwise stated.
CHAQ: childhood health assessment questionnaire;
cJADAS: clinical juvenile arthritis disease activity score;
IQR: interquartile range; VAS: visual analog scale.
Gordon J. Hendry et al.
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observed for resolution of walking disability, from 23%
for baseline to 6 months, 13% at 6 months to 1 year, re-
ducing to 7% at 4–5 years. Imputed estimates consis-
tently exceeded original data for resolved walking
disability.
Transitions and trajectories of walking disability
For all follow-ups over the full 5-year study period there
were a total of 3907 transitions for walking disability
states observed for the entire sample (Table 2). The
most frequently observed sequences were maintenance
of no walking disability (n¼2243, 57.4%) and mainte-
nance of moderate walking disability (n¼518, 13.2%)
between two consecutive follow-ups. A total of 485
(12.4%) transitions were observed for at least mild walk-
ing disability to no walking disability.
The riverplots (Fig. 4A and B) reveal two main concen-
trations of participants, one with a stable absence of
walking disability and the other with persistent moderate
walking disability over 5 years of follow-up. The plots
also reveals a frequent fluctuating course of walking dis-
ability, with deterioration and improvement between ab-
sent, mild and moderate walking disability states. There
are also concentrations of trajectories to and from miss-
ing data to absent disability across the 5-year follow-up
period (Fig. 4A).
Discussion
This study represents the first large-scale longitudinal
evaluation of lower limb joint involvement and walking
disability from the point of diagnosis in children with JIA.
FIG. 1 Relative frequencies of active (A) and limited (B) joints, including imputed values
Juvenile arthritis walking disability
https://academic.oup.com/rheumap 5
D
ow
nloaded from
 https://academ
ic.oup.com
/rheum
ap/article-abstract/2/2/rky039/5106174 by U
niversity C
ollege London user on 06 February 2019
These results suggest that prevalence rates for knee
and ankle joint synovitis and joint limitation of motion
are high at initial presentation and then stabilize with the
initiation of medical therapies. Joint impairments at the
hip, subtalar and small foot joints were infrequently ob-
served over the 5-year study and somewhat contrary to
previous study findings [2, 9, 12, 13].
Assessments of active and limited joint counts have
been shown frequently to underestimate lower limb sy-
novitis relative to more sensitive imaging techniques
[23–27]. Expert consensus guidance on imaging in JIA
concluded that ultrasound and MRI are superior to clini-
cal examination in the evaluation of joint inflammation
[28]. The entity of subclinical synovitis is not currently
well understood, but evidence suggesting its presence
might predict future JIA relapses [29]. The low preva-
lence of hip, subtalar and foot synovitis in the present
study suggests that the role of imaging requires further
consideration.
Persistent synovitis may be problematic at the knee
and ankle for a small proportion of children with JIA.
This finding is in agreement with previous studies dem-
onstrating that several distinct disease activity courses
exist, including moderate increasing and persistent
moderate trajectories, which account for 25% of
patients with JIA [30, 31]. This is an important finding
because previous studies have demonstrated that per-
sistent disease activity is associated with radiographic
progression and reduced physical function [32, 33].
Ankle joint synovitis appears to be associated with
unfavourable disease outcome characterized by failure
to achieve remission [34, 35]. The prognosis for lower
limb disease activity overall appears to be good, with
low a prevalence of lower limb disease activity observed
for all lower limb joints after 1 year.
Although the prevalence of walking disability de-
creased from 52 to 32% at 1-year follow-up, an impor-
tant finding was that at least mild walking disability
affected 25–31% of cases after 1 year despite low prev-
alence rates of lower limb synovitis. In addition, the ma-
jority of those reporting walking disability were in the
moderate category, which is indicative of much difficulty
in walking or climbing steps. Persistent walking disability
also appeared to be problematic for some participants,
where 16–22% reported walking disability at two con-
secutive follow-ups on at least one occasion after
1 year. Together with analyses of transitions and trajec-
tories of walking disability in this cohort, these findings
support the theory that walking disability incorporates
both reversible and irreversible components, which
have been confirmed in studies of overall physical func-
tion [3, 16].
FIG. 2 Relative frequencies for changes in disease activity
(A) Knee open cohort. (B) Knee imputed values. (C) Ankle open cohort. (D) Ankle imputed values. Dark blue: inactive
stable; red: active stable; green: new active; purple: active resolved. Total n for closed cohort transitions between
time points are as follows: 0–6 months, n¼ 819; 6 months–1 year, n¼734; 1–2 years, n¼660; 2–3 years, n¼521; 3–
4 years, n¼376; 4–5 years, n¼ 274.
Gordon J. Hendry et al.
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Walking disability in children and young people with
JIA is likely to be multifactorial and might be influenced
by reduced muscle strength and endurance, impaired
motor function, balance and proprioception [36–39]. Gait
compensations are often consistent with the avoidance
of pain, stiffness and exacerbations of disease, whereby
children walk more slowly, less often and less far,
followed by deconditioning attributable to reductions in
physical activity [40]. There is strong evidence demon-
strating that children with JIA are significantly less active
than healthy children [41, 42]. Low levels of physical ac-
tivity in childhood are not trivial and have been associ-
ated with poor body composition (e.g. increased fat,
decreased lean muscle, poor bone health) and elevated
cardiovascular disease risk in later life [43, 44]. In addi-
tion, walking disability may occur as a result of the
FIG. 3 Relative frequencies (percentage of n) for walking disability over 5 years
(A) Open cohort (baseline, n¼ 737; 6 months, n¼ 669; 1 year, n¼727; 2 years, n¼ 663; 3 years, n¼ 592; 4 years,
n¼ 519; 5 years, n¼ 454). (B) Closed cohort (n¼ 173). Light blue: no disability; red: mild walking disability; green: mod-
erate walking disability; purple: severe walking disability. (C and D) Relative frequencies (percentage of n) for changes in
walking disability state between each successive follow-up for: (C) open cohort (0–6 months, n¼ 502; 6 months–1 year,
n¼ 537; 1–2 years, n¼544; 2–3 years, n¼496; 3–4 years, n¼ 426; 4–5 years, n¼374), and (D) open cohort with imputed
data. Dark blue: no disability; red: stable disability; green: new disability; purple: resolved disability.
TABLE 2 Transition sequence rates between each walking disability state
Transitions to
Transitions from ﬁ CHAQ_0 ﬁ CHAQ_1 ﬁ CHAQ_2 ﬁ CHAQ_3 Total (rows)
CHAQ_0! 2243 (57.4) 128 (3.3) 185 (4.7) 1 (0.03) 2557 (65.4)
CHAQ_1! 184 (4.7) 81 (2.1) 95 (2.4) 1 (0.03) 361 (9.2)
CHAQ_2! 283 (7.2) 117 (3.0) 518 (13.3) 12 (0.3) 930 (23.8)
CHAQ_3! 18 (0.5) 4 (0.1) 30 (0.8) 7 (0.2) 59 (1.5)
Total (columns) 2728 (69.8) 330 (8.4) 828 (21.2) 21 (0.5) 3907
Data are reported as n (%). Each row represents the starting sequence of transition from each walking disability state,
whereas each column represents the end sequence of transition to each walking state. CHAQ: childhood health assess-
ment questionnaire.
Juvenile arthritis walking disability
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presence of disease-related extra-articular features,
such as tenosynovitis, enthesitis in participants with
enthesitis-related arthritis or dactylitis in PsA. Data on
extra-articular features were not routinely collected for
each study participant and therefore were not included
in the analyses in the present study.
There was no specific measure of lower limb function
collected as part of the CAPS inception cohort study.
As such, we used the CHAQ walking subscale for these
analyses. A similar approach has been adopted in adults
with RA, where no tool designed specifically to measure
lower limb function was available [45]. This novel ap-
proach has some advantages in that the CHAQ is com-
monly administered as part of routine care for JIA, and
it has excellent validity, reliability and responsiveness to
change [46]. Moreover, normative data are available
FIG. 4 Trajectories for childhood health assessment questionnaire walking disability levels from baseline to 5-year fol-
low-up
The riverplot illustrates the proportion of participants with different levels of walking disability or missing data over time.
Each participant’s trajectory is illustrated by a single line. The thickness of the line at a node is proportional to the per-
centage of participants at that level of walking disability. (A) Riverplot depicting individual sequential trajectories for
CHAQ walking disability ordinal data (open cohort). Thicker lines for no walking disability (none) suggest that a large pro-
portion had no walking disability, whereas relatively few had severe walking disability. (B) Riverplot depicting CHAQ
walking disability trajectories for the closed cohort (n¼173). CHAQ: childhood health assessment questionnaire.
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from 221 controls for comparison, and this suggests
that healthy children will have a mean (S.D.) score of
0 (0.2) on the CHAQ walking subscale [20]. Given the
simplicity of the CHAQ walking subscale, which is de-
rived from only two items (Are you/is your child able to:
walk outside on flat ground; and climb up five steps?), it
is probable that other important aspects of walking
(such as the ability to run or walk on uneven ground)
are not captured using this subscale. Individual mea-
surement properties of the CHAQ walking disability sub-
scale remain largely unknown; however, previous
studies have demonstrated that this subscale has high
internal consistency (Cronbach’s a¼0.7–0.93) [20, 46].
There are some limitations of the present study concern-
ing the analyses of an open cohort. This cohort was sub-
ject to high drop-out rates and missing data because data
items were collected as part of routine clinical visits, which
might result in selection bias. Moreover, the CAPS
recruited from tertiary centres of paediatric rheumatology,
which may be more likely to include the most severe
cases. A strength of this study is that the potential for se-
lection bias was minimized in three different ways. First,
prevalence estimates and transitions for lower limb impair-
ments and walking disability at baseline and over the 5-
year follow-up periods were compared by computing open
and closed cohort and imputed data (for selected varia-
bles). These estimates remained largely consistent across
all analyses, suggesting a low risk of selection bias.
Second, baseline characteristics between closed and
open cohorts were compared and revealed only modest
differences for age, symptom duration, PGA and disability
score. Third, multiple imputation was adopted according
to previously accepted assumptions [21]. Selection bias in
patients with full follow-up is concluded to be minimal;
however, the possibility of a slight overestimation of lower
limb impairments and disability is acknowledged.
Given the length of time between annual follow-ups, it
is likely that several fluctuations in joint impairments or
walking disability might have taken place between meas-
urements that might not have been captured. Indeed,
persistent disease as observed over two follow-ups sep-
arated by 1 year might in fact be more reflective of two
flares in a joint separated by periods of relative quies-
cence. Therefore, it is acknowledged that careful inter-
pretation is required for persistence of outcomes over
time as presented in this study.
Conclusion
Prevalence rates for lower limb synovitis and walking
disability are initially high and then stabilize. The progno-
sis for lower limb impairments is generally good over
5 years; however, walking disability often persists in
spite of low prevalence of lower limb disease activity.
This study provides evidence of both persistent walking
disability and three distinct trajectories of walking dis-
ability, including persistent moderate and fluctuating.
The results necessitate further research to clarify the
relationships between lower limb impairments and walk-
ing disability in JIA. There might be an unmet need for
non-medical strategies designed to prevent and/or re-
solve persistent walking disability in JIA.
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